日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma.

尿激酶受体/uPAR 是吉西他滨治疗的胰腺导管腺癌中 p53 功能获得性突变的主要效应因子

Zampieri Carlotta, Kouhmareh Kourosh, Sartipdolagh Parnian, Azmoon Pardis, Klemke Richard L, Gonias Steven L

LDL receptor-related protein-1 regulates NFκB and microRNA-155 in macrophages to control the inflammatory response

LDL受体相关蛋白-1通过调节巨噬细胞中的NFκB和microRNA-155来控制炎症反应。

Mantuano, Elisabetta; Brifault, Coralie; Lam, Michael S; Azmoon, Pardis; Gilder, Andrew S; Gonias, Steven L